Form 4: Editas Medicine Executive Sells Shares
Insider Transaction (Form 4)
Linda Burkly, EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc., sold 4,928 shares of common stock on July 28, 2026 for $2.67 per share.
Summary
- Open-market sale: disposed of 4,928 Common Stock at $2.67 ($13,158) on July 28, 2026; holds 62,369 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $13,158 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Linda Burkly — Officer (EVP, CHIEF SCIENTIFIC OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Open-market sale | Common Stock | 4,928 | $3 | $13.2K | 62,369 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Open-market sale (4,928 shares) |
Keywords
insider transaction, Form 4, EDIT, Editas Medicine, Inc., bearish, Linda Burkly
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.